Celebrating 20 years of innovation - Discover how we've been a catalyst for regional growth and UK innovation for over two decades in CPI's Annual Review 2023-2024.
A digital future for the process industries with new Ayrshire technology centre
The new technology centre will help process manufacturing industries embrace emerging technologies and fast track a net-zero future.
Jun 09 2022
£4.8 million funding for Deep Branch and CPI to scale CO2-to-protein novel food platform
Together with Deep Branch, we’ve received £4.8 million in funding from the UK government’s Department for Business, Energy and Industrial Strategy.
Jun 07 2022
Revolutionary new oral medicine to treat inflammatory bowel disease developed by industry collaboration
An innovative capsule could take the gold-standard treatment for Crohn’s disease and ulcerative colitis out of hospital and into homes for the first time.
May 19 2022
CPI expands into the North West at Liverpool Science Park
We’ve officially launched our first North West base in Liverpool Science Park, which will help us to drive innovation and economic growth in the region.
Apr 06 2022
CPI establishes presence at Newcastle’s Helix quarter
We have moved into The Catalyst building on Newcastle Helix, which brings together industry leaders, businesses, and researchers in an innovation cluster.
Mar 31 2022
CPI and the University of Liverpool formalise partnership
We’ve signed a Memorandum of Understanding (MoU) with the University of Liverpool to boost research and innovation partnerships in Liverpool City Region.
Mar 10 2022
North East ageing and tech experts launch project to support businesses in innovating for the ageing population
A project between CPI, the National Innovation Centre for Ageing and the North of Tyne Combined Authority will improve wellbeing through tech innovation.
Mar 09 2022
Welcoming four new appointments to our Board
Catherine Quinn, George Gillespie, Jez Maiden, and Myrtle Dawes join CPI’s board as Non-Executive members
Mar 01 2022
CPI joins partnership to tackle the early diagnosis of Parkinson’s disease
We’ve joined a new partnership to develop a scaled manufacturing process for α‑synuclein protein to support the early diagnosis of Parkinson’s disease.
